SMS Pharmaceuticals Ltd — Capital/Financing Update 2025

Mar 27, 2025

==> picture [241 x 158] intentionally omitted <==

Date: 27[th] March, 2025

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security Code: 532815 Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Allotment of 40,00,000 Equity Shares pursuant to exercise of Warrants allotted on preferential basis

This is in furtherance to our letter dated on 19th March, 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”), we hereby inform you that the Securities Allotment Committee of the Board of Directors of SMS Pharmaceuticals Limited (“the Company”) at its meeting held today i.e. 27[th] March, 2025 has allotted 40,00,000 equity shares of face value of Rs.1/- each, on conversion of 40,00,000 Warrants to 2 Allottees, upon receipt of the balance amount aggregating to Rs. 38,10,00,000 (Thirty-Eight Crores and Ten Lakhs only) at the rate of Rs.95.25/- (Rupees Ninety-Five Rupees and Twenty-Five Paise Only) per Warrant (being 75% of the Issue Price per Warrant) pursuant to the exercise of their rights of conversion of Warrants into equity shares in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as per the details given in Annexure I.

These equity shares allotted on conversion of the warrants, shall rank pari-passu in all respects with the existing equity shares of the Company.

Consequent to the said allotment, the paid up share capital of the Company stands increased to Rs. 8,86,52,030/- divided into 8,86,52,030 equity shares of face value of Re. 1/- each from Rs.8,46,52,030 divided into 8,46,52,030 equity shares of face value of Re.1/each.

==> picture [241 x 158] intentionally omitted <==

Disclosures under Regulation 30 of SEBI Listing Regulations read with SEBI Master Circular No.SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 ("SEBI Circular”), are provided in ‘Annexure II’.

You are requested to take the above information on records.

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2025.03.27 17:29:53 +05'30' Thirumalesh Tumma Company Secretary

==> picture [241 x 158] intentionally omitted <==

Annexure I

List of Allottees :

Name of the Allottees	No. of Warrants held	No. of equity shares of face value of Rs1/- each allotted, upon conversion/ exchange of Warrants	No. of warrants outstanding for Conversion
Ramesh Babu Potluri	25,00,000	25,00,000	-
Potluri Infra Projects LLP	15,00,000	15,00,000	-
Total	40,00,000	40,00,000	-

==> picture [241 x 158] intentionally omitted <==

Annexure II

The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular are as under:

Sl No	Particulars	Description
1	Type of securities issued	Equity Shares pursuant to exercise of warrants.
2	Type of issuance	Preferential allotment
3	Total number of securities issued or the total amount for which the securities issued (approximately)	Allotment of 40,00,000 Equity Shares of face value of Re. 1/- each upon exercise of equal number of Warrants at an issue price of Rs. 127/-each (including a Premium of Rs.126/-) upon receipt of balance consideration of Rs. 95.25/- per warrant (being 75% of the Warrant Issue Price) aggregating to Rs. 38,10,00,000 (ThirtyEight Crores Ten Lakhs only)
	Additional information in case of preferential issue:
4	Name of the Allottee	As per Annexure-I
5	Post allotment of securities Outcome of the subscription, Issue price / allotted price (in case of convertibles), Number of investors	As per Annexure-I Pursuant to this allotment, the paid up share capital of the Company stands increased to Rs. 8,86,52,030/- consisting of 8,86,52,030 equity shares of Re. 1/- each. 90,00,000 convertible warrants were allotted on 19thMarch 2024 at an issue price of Rs.127/- per warrant, carrying a right to subscribe to 1 Equity Share per warrant on receipt of amount at the rate of Rs. 31.75/- per warrant (being 25% of the issue price per warrant). Presently, 40,00,000 Equity Shares have been allotted on receipt of balance amount at the rate of Rs. 95.25/- per warrant (being 75% of the issue price per warrant.) The option of Conversion exercised by 2 warrant holders

==> picture [241 x 158] intentionally omitted <==

	6	In case of convertibles - intimation on conversion of securities or on lapse of the tenure of the instrument;	Equity shares are being allotted upon exercise of Warrants.